PHARMACIE DEBELLE
0837.307.562 · rovalta.com · 26/09/2026
PHARMACIE DEBELLE
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOPHARMACIE DEBELLE is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0837.307.562
- Legal form
- Private limited company
- Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2024
Joint committees (1)
- 313
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 293,8 k € | -23.0% | 381,5 k € | +21.9% | 313 k € | -15.5% | 370,3 k € | +13.9% | 325 k € |
| EBITDA | 115,4 k € | -27.8% | 160 k € | +75.4% | 91,2 k € | -55.0% | 202,6 k € | +33.1% | 152,2 k € |
| Operating result | 99 k € | -13.4% | 114,3 k € | +128% | 50,1 k € | -71.6% | 176,1 k € | +38.0% | 127,6 k € |
| Net result | 69,2 k € | -8.4% | 75,5 k € | +135% | 32,2 k € | -72.9% | 118,7 k € | +42.1% | 83,5 k € |
| Balance sheet | |||||||||
| Equity | 558,7 k € | +14.1% | 489,5 k € | +12.0% | 437,2 k € | -1.8% | 445 k € | +24.9% | 356,3 k € |
| Total assets | 643,6 k € | -6.1% | 685,1 k € | +1.3% | 676,6 k € | +17.5% | 575,8 k € | +5.9% | 543,8 k € |
| Cash | 447,2 k € | +219% | 140,2 k € | +32.8% | 105,6 k € | -2.4% | 108,2 k € | +74.0% | 62,2 k € |
| Debts | 84,9 k € | -56.6% | 195,7 k € | -18.3% | 239,4 k € | +83.0% | 130,8 k € | -30.2% | 187,5 k € |
| Other | |||||||||
| Workforce | – | 4,3 ETP | 0.0% | 4,3 ETP | +19.4% | 3,6 ETP | -2.7% | 3,7 ETP | |
Board of directors
Source · NBB, accounts to 31/12/20242 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2025 | 27/06/2024 | 16/06/2023 | 19/04/2022 | 29/06/2021 | 28/05/2020 |
| General meeting | 12/06/2025 | 11/05/2024 | 12/06/2023 | 07/04/2022 | 11/06/2021 | 09/05/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 12/06/2025 | 23/06/2025 | French | |
| Abridged model | 31/12/2023 | 11/05/2024 | 27/06/2024 | French | |
| Abridged model | 31/12/2022 | 12/06/2023 | 16/06/2023 | French | |
| Abridged model | 31/12/2021 | 07/04/2022 | 19/04/2022 | French | |
| Abridged model | 31/12/2020 | 11/06/2021 | 29/06/2021 | French | |
| Abridged model | 31/12/2019 | 09/05/2020 | 28/05/2020 | French | |
| Abridged model | 31/12/2018 | 26/06/2019 | 05/07/2019 | French | |
| Abridged model | 31/12/2017 | 07/06/2018 | 11/06/2018 | French | |
| Abridged model | 31/12/2016 | 20/06/2017 | 29/06/2017 | French | |
| Abridged model | 31/12/2015 | 03/06/2016 | 14/06/2016 | French | |
| Abridged model | 31/12/2014 | 22/07/2015 | 07/08/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 01/07/2014 | French | |
| Abridged model | 31/12/2012 | 11/06/2013 | 09/07/2013 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20242 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution24/06/2025RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...) - DEMISSIONS, NOMINATIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring11/04/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Mandates13/02/2025DEMISSIONS, NOMINATIONS
- Mandates07/11/2024DEMISSIONS, NOMINATIONS
- Registered office11/10/2024SIEGE SOCIAL
- Mandates27/03/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Capital / shares26/10/2011CAPITAL, ACTIONS
- Other29/06/2011RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202469,2 k €↓
- 2024Name changePHARMACIE DEBELLE
- 2023Annual accounts 202375,5 k €↑
- 2022Annual accounts 202232,2 k €↓
- 2021Annual accounts 2021118,7 k €↑
- 2021Name changeDEBELLE PHARMACIE
- 2020Annual accounts 202083,5 k €↑
- 2019Annual accounts 201961,9 k €↑
- 2018Annual accounts 201853,9 k €↑
- 2017Annual accounts 201723,3 k €↓
- 2016Annual accounts 201667,3 k €↑
- 2015Annual accounts 201545,2 k €↑
- 2014Annual accounts 201419,9 k €↓
- 2013Annual accounts 201320,4 k €↑
- 2012Annual accounts 2012-1,7 k €